"A significant event": CBD-based pharma drug Epidiolex presented to FDA for approval

http://www.thecannabist.co/2017/11/03/cbd-epidiolex-fda-nda-gw-pharmaceuticals-pharmaceutical-drug/91562/ GW Pharmaceuticals, a.k.a. Greenwich Biosciences, has submitted to the FDA a New Drug Application for Epidiolex, a cannabis-based epilepsy drug with CBD.

The post “A significant event”: CBD-based pharma drug Epidiolex presented to FDA for approval appeared first on Marijuana News.

Source: MJFeed